Francesco Marincola
About Francesco Marincola
Chief Scientific Officer Francesco Marincola
Francesco Marincola serves as the Chief Scientific Officer with a background that spans over three decades in research and development. His expertise is primarily focused on immunology, oncology, and cell therapy. Over his illustrious career, he has held numerous leadership positions, contributing significantly to advancements in adoptive cell therapy and CRISPR circuits for therapeutic programs.
Francesco Marincola's Education and Expertise
Francesco Marincola received his M.D. from the University of Milan and completed his residency at Stanford University. With deep expertise in immunology, oncology, and cell therapy, he brings over 30 years of research experience to his current role. His scholarly work includes over 600 peer-reviewed publications, making him a prominent figure in the medical research community.
Francesco Marincola's Tenure at Kite Pharma
At Kite Pharma, Francesco Marincola served as Senior Vice President and Global Head of Research. During his tenure, he was instrumental in developing research strategies for adoptive cell therapy products, contributing to the company's status as a leader in cancer immunotherapy. His work at Kite Pharma underscores his significant impact on the field of cell-based cancer treatments.
Francesco Marincola's Leadership Roles
Francesco Marincola has held several key leadership positions, including President and Chief Scientific Officer at Refuge Biotechnologies, Chief Research Officer at Sidra Medical and Research Centre, and Distinguished Research Fellow in Immune Oncology at AbbVie. His leadership has been pivotal in guiding research and development across multiple organizations, particularly in the realms of immunotherapy and biotechnology.
Francesco Marincola's Contributions to National Institutes of Health
Francesco Marincola spent over two decades at the National Institutes of Health (NIH) and the National Cancer Institute (NCI). He served as a tenured senior investigator in cancer immunotherapy and biomarker research, and as Chief Infectious Disease and Immunogenetics Investigator at the NIH Clinical Center. His extensive work at NIH has contributed to significant advancements in cancer immunotherapy.
Francesco Marincola's Editorial Roles
Francesco Marincola serves as Editor-in-Chief for several peer-reviewed medical journals, including the Journal of Translational Medicine, Translational Medicine Communications, and Immunotherapy. His editorial leadership reflects his ongoing commitment to advancing scientific knowledge and dissemination in the fields of immunology and translational medicine.